Green Cross becomes largest shareholder of Innocell

Published: 2012-08-20 06:56:00
Updated: 2012-08-20 06:56:00
Green Cross Corp. recently purchased 23.43 percent in shares of Innocell, a Korean cell therapeutics company.

The company announced Thursday in a regulatory filing that it acquired Innocell as the largest shareholder to increase its managerial control over the biopharmaceutical firm.

The eq...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.